Kastalia is Filter‘s deputy editor. She previously worked at half a dozen mainstream digital media outlets and would not recommend the drug coverage at any of them. For a while she was a syringe program peer worker in NYC, where she did outreach hep C testing and navigated participants through treatment. She also writes with Jon Kirkpatrick.
The Drug Enforcement Administration is allowing pharmaceutical companies to produce a higher volume of Vyvanse and its generic versions. The…
On September 3, attorneys general representing 19 states and the District of Columbia filed an amicus brief with the Supreme…
New York Governor Kathy Hochul has never been outspoken about overdose prevention centers (OPC). But since taking office in January…
On August 26, pharmaceutical manufacturer Indivior announced that it had begun supplying the Biomedical Advanced Research and Development Authority (BARDA)…
On August 26, the Federal Communications Commission (FCC) issued final rulings on multiple outstanding issues related to its recent order…
In early August, 11 New York State corrections officers (COs) were at the scene of a medical emergency involving someone…
Beginning September 1, the Oklahoma Department of Corrections (ODOC) will no longer deliver physical mail to the nearly 23,000 people…
On August 7 the Food and Drug Administration approved an opioid overdose antidote developed by Purdue Pharma that contains nalmefene,…
Back when I was at the science desk at Newsweek, they used to bring in young reporters on $38,000 a…
On July 30, the Substance Use and Mental Health Services Administration released its annual survey on substance use, mental illness,…